SuperworthAmylyx Pharmaceuticals market cap AMLX
Share price times shares outstanding: what the whole company sells for, since 2022.
- Today, Oct 23, 2026
- $3B
- Highest close in our data
- $4.3B
- Aug 2026
Amylyx Pharmaceuticals is worth $3B at the close on Oct 23, 2026, at $27.20 a share.
That is up 140% over the last year.
Its highest close in our data was $4.3B in Aug 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $3B | $1.3B | $4.3B | +124% |
| 2025 | $1.4B | $224.8M | $1.6B | +410% |
| 2024 | $265.3M | $111.5M | $1.3B | −73% |
| 2023 | $993.9M | $814.9M | $2.7B | −59% |
| 2022 | $2.4B | $494.6M | $2.6B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Amylyx Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| AMLXAmylyx Pharmaceuticals | $3B |
| NRIXNurix Therapeutics | $2.8B |
| OGNOrganon | $3.6B |
| LQDALiquidia | $3.8B |
| ARQTArcutis Biotherapeutics | $3.9B |
| PBHPrestige Consumer Healthcare | $2.3B |
| INDVIndivior Pharmaceuticals | $4.1B |
| HRMYHarmony Biosciences | $2.1B |
| ANIPANI Pharmaceuticals | $1.7B |
| PAHCPhibro Animal Health | $1.6B |
| KNSAKiniksa Pharmaceuticals International | $6B |
| Peer median | $3.2B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Amylyx Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.